Biolase (NASDAQ:BIOL) Given Daily News Sentiment Score of 0.12
Media headlines about Biolase (NASDAQ:BIOL) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a …